Loading…
Advanced Energy Industries
$10.9B
Market Cap
54.5
P/E
0.97
PEG
12.3%
ROCE
11.6%
ROE
0.48
D/E
9.3%
OPM
-29.2%
% from 52W High
81
α RS
🔍 AEIS is showing a high-conviction setup because it matches 4 of 37 tracked screener presets, RS Rating is 81, and an ECS of 85.5 last quarter. Net: Broad signal stack, not a recommendation. ? Conviction RS Rating ECS
Sources
Conviction 4/37 · RS Rating 81 · ECS 85.5
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for AEIS including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Advanced Energy Industries, Inc. provides precision power conversion, measurement, and control solutions in the United States, Asia, Europe, and internationally.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding AEIS
View All Superinvestors →
Manager Shares Value % of Fund Period
Steve Cohen Point72 Asset Management 96.5K $31.2M 0.04% Mar 2026
Jim Simons Renaissance Technologies LLC 2.3K $749K 0.00% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →
📊 MIXED Advanced Energy Q1 2026 revenue $511M, up 26% YoY; raised FY growth target to low-mid 20%.
Revenue & Profitability
Q1 2026 revenue was $511 million, above guidance midpoint, up 26% year-over-year. Gross margin was 40.1%, up 220 bps YoY. Operating income reached a record $98 million, with operating margin of 19.1% (up 560 bps YoY). Non-GAAP EPS was $2.09, up 70% YoY, exceeding guidance. The company generated adjusted EBITDA of $108 million, also a record.
Outlook
Management sees strengthening demand across all markets in 2026, with an increasing growth trajectory. Semiconductor demand is expected to accelerate in Q2 and into the second half, driven by leading-edge node investments. Data center demand remains very strong, though downstream supply constraints cause near-term volatility. Industrial medical is recovering from a two-year inventory correction, with bookings up 14% sequentially. Telecom and networking growth is supported by AI-related networking programs.
Growth Drivers
Key growth drivers include widespread adoption of eVerest, eVoS, and NavX in semiconductor, raising full-year growth expectation to low-to-mid 20% overall. Data center computing growth is expected to be mid-30% for the full year, driven by AI capacity investments and second-wave customer wins. In industrial medical, recovery and multiple design wins in therapeutic, diagnostic, and life science applications are expected to drive sequential revenue growth. Telecom and networking benefits from AI-related production ramps.
Balance Sheet & CapEx
Q1 2026 CapEx was $37 million. Full-year 2026 CapEx is now guided to $170-$180 million, up slightly due to early investments in the new Thailand factory. The company is expanding capacity in Malaysia, the Philippines, and Mexico, and expects to exit 2026 with over $2.5 billion in revenue-generating capacity. The Thailand facility (500,000 sq ft) will add over $1 billion in additional capacity once fully built out, with initial production for data center and semiconductor products planned for late 2026/early 2027.
Margins
Q1 2026 gross margin was 40.1%, up 40 bps sequentially and 220 bps YoY, exceeding guidance due to better product mix and lower other cost of sales. Management expects gross margin to improve 20-50 bps sequentially in Q2 and further throughout the year, supported by new product mix, higher volumes, and factory efficiency. The long-term target is gross margin above 43%, driven by higher-value new products and manufacturing improvements.
Key Risks
Management flagged risks including downstream supply constraints that could limit data center revenue, tariff expenses that continue to impact cost, and demand mix volatility due to frequent customer changes. Factory capacity prioritization in Q1 limited industrial medical output. Additionally, tightness in component supply and increasing input costs are being monitored, though the company is building inventory to mitigate.
Generated by AI · Q1 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-08-03
Record Q2 results with 30% revenue growth and 83% EPS increase, driven by strong demand in semiconductor and data center markets. Guidance raised for 2026, with revenue growth now expected in the low-to-mid 30% range and continued margin expansion.
Q1 2026 Q1 2026 2026-05-04
Revenue grew 26% year-over-year with record data center results and gross margin above 40%. Full-year growth targets were raised, driven by strong demand in semiconductor and data center, while capacity expansions and new product wins position the company for continued outperformance.
Q4 2025 Q4 2025 2026-02-10
Q4 2025 delivered strong results with revenue and EPS above guidance, driven by record data center and solid semiconductor growth. 2026 outlook calls for high-teens revenue growth, gross margin near 40%, and continued capacity expansion to meet robust AI and semiconductor demand.
Q3 2025 Q3 2025 2025-11-04
Q3 revenue and earnings surpassed guidance, led by record data center growth and improved margins from cost savings. 2025 revenue outlook was raised to 20% growth, with data center revenue expected to more than double and strong momentum projected into 2026.
Q2 2025 Q2 2025 2025-08-05
Q2 revenue and EPS exceeded guidance, led by surging data center demand and improved margins despite tariff headwinds. 2025 revenue growth is projected at 17%, with data center growth now expected to exceed 80% and gross margin to approach 40% by year-end.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.